Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1979 1
1980 1
1981 1
1982 1
1983 1
1984 2
1985 1
1986 1
1989 1
1993 1
1995 1
1996 2
1997 6
1998 2
1999 2
2000 10
2002 3
2003 6
2004 8
2005 13
2006 7
2007 19
2008 22
2009 17
2010 18
2011 30
2012 27
2013 18
2014 20
2015 27
2016 30
2017 34
2018 31
2019 40
2020 55
2021 62
2022 46
Text availability
Article attribute
Article type
Publication date

Search Results

498 results
Results by year
Filters applied: . Clear all
Page 1
Physical Exercise and Neuroinflammation in Major Depressive Disorder.
Ignácio ZM, da Silva RS, Plissari ME, Quevedo J, Réus GZ. Ignácio ZM, et al. Among authors: da silva rs. Mol Neurobiol. 2019 Dec;56(12):8323-8335. doi: 10.1007/s12035-019-01670-1. Epub 2019 Jun 21. Mol Neurobiol. 2019. PMID: 31228000 Review.
Updated results from the phase 3 HELIOS study of ibrutinib, bendamustine, and rituximab in relapsed chronic lymphocytic leukemia/small lymphocytic lymphoma.
Fraser G, Cramer P, Demirkan F, Silva RS, Grosicki S, Pristupa A, Janssens A, Mayer J, Bartlett NL, Dilhuydy MS, Pylypenko H, Loscertales J, Avigdor A, Rule S, Villa D, Samoilova O, Panagiotidis P, Goy A, Pavlovsky MA, Karlsson C, Hallek M, Mahler M, Salman M, Sun S, Phelps C, Balasubramanian S, Howes A, Chanan-Khan A. Fraser G, et al. Among authors: silva rs. Leukemia. 2019 Apr;33(4):969-980. doi: 10.1038/s41375-018-0276-9. Epub 2018 Oct 12. Leukemia. 2019. PMID: 30315239 Free PMC article. Clinical Trial.
Ibrutinib versus temsirolimus in patients with relapsed or refractory mantle-cell lymphoma: an international, randomised, open-label, phase 3 study.
Dreyling M, Jurczak W, Jerkeman M, Silva RS, Rusconi C, Trneny M, Offner F, Caballero D, Joao C, Witzens-Harig M, Hess G, Bence-Bruckler I, Cho SG, Bothos J, Goldberg JD, Enny C, Traina S, Balasubramanian S, Bandyopadhyay N, Sun S, Vermeulen J, Rizo A, Rule S. Dreyling M, et al. Among authors: silva rs. Lancet. 2016 Feb 20;387(10020):770-8. doi: 10.1016/S0140-6736(15)00667-4. Epub 2015 Dec 7. Lancet. 2016. PMID: 26673811 Clinical Trial.
Ineffective health control: concept analysis.
Santos WND, Silva RSD, Souza FMLC, Santos RSDC, Oliveira IC, Silva RARD. Santos WND, et al. Among authors: silva rsd. Rev Bras Enferm. 2021 Mar 24;74(1):e20190158. doi: 10.1590/0034-7167-2019-0158. eCollection 2021. Rev Bras Enferm. 2021. PMID: 33787772 Free article. English, Portuguese.
Postpartum depression: a case-control study.
Silva RS, Junior RA, Sampaio VS, Rodrigues KO, Fronza M. Silva RS, et al. J Matern Fetal Neonatal Med. 2021 Sep;34(17):2801-2806. doi: 10.1080/14767058.2019.1671335. Epub 2019 Oct 3. J Matern Fetal Neonatal Med. 2021. PMID: 31581862
Highlighting COVID-19: What the imaging exams show about the disease.
de Carvalho LS, da Silva Júnior RT, Oliveira BVS, de Miranda YS, Rebouças NLF, Loureiro MS, Pinheiro SLR, da Silva RS, Correia PVSLM, Silva MJS, Ribeiro SN, da Silva FAF, de Brito BB, Santos MLC, Leal RAOS, Oliveira MV, de Melo FF. de Carvalho LS, et al. Among authors: da silva rs. World J Radiol. 2021 May 28;13(5):122-136. doi: 10.4329/wjr.v13.i5.122. World J Radiol. 2021. PMID: 34141092 Free PMC article. Review.
Ibrutinib combined with bendamustine and rituximab compared with placebo, bendamustine, and rituximab for previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (HELIOS): a randomised, double-blind, phase 3 study.
Chanan-Khan A, Cramer P, Demirkan F, Fraser G, Silva RS, Grosicki S, Pristupa A, Janssens A, Mayer J, Bartlett NL, Dilhuydy MS, Pylypenko H, Loscertales J, Avigdor A, Rule S, Villa D, Samoilova O, Panagiotidis P, Goy A, Mato A, Pavlovsky MA, Karlsson C, Mahler M, Salman M, Sun S, Phelps C, Balasubramanian S, Howes A, Hallek M; HELIOS investigators. Chanan-Khan A, et al. Among authors: silva rs. Lancet Oncol. 2016 Feb;17(2):200-211. doi: 10.1016/S1470-2045(15)00465-9. Epub 2015 Dec 5. Lancet Oncol. 2016. PMID: 26655421 Clinical Trial.
498 results